Abstract: When Alzheimer's disease (AD) progresses, several pathological features arise including accumulation of misfolded protein aggregates [e.g., amyloid-β (Aβ) plaques], metal ion dyshomeostasis, and oxidative stress. These characteristics are recently suggested to be interconnected through a potential factor, metal-associated Aβ (metal−Aβ) species. The role of metal-Aβ species in AD pathogenesis remains unclear, however. To elucidate the contribution of metal-Aβ species to AD pathology, as well as to develop small molecules as chemical tools and/or theranostic (therapeutic and diagnostic) agents for this disease, curcumin (Cur), a natural product from turmeric, and its derivatives have been studied towards both metal-free and metal-induced Aβ aggregation. Although Cur has indicated anti-amyloidogenic activities and antioxidant properties, its biological use has been hindered due to low solubility and stability in physiologically relevant conditions. Herein, we report the reactivity of Cur and its derivatives (Gd-Cur, a potential multimodal Aβ imaging agent; Cur-S, a water soluble derivative of Cur that has substitution at the phenolic hydroxyls) with metal-free Aβ and metal−Aβ species. Our results and observations indicate that Gd-Cur could modulate Cu(II)-triggered Aβ aggregation more noticeably over metal-free or Zn(II)-induced analogues; however, Cur-S was not observed to noticeably modulate Aβ aggregation with and without metal ions. Overall, our studies present information that could aid in optimizing the molecular scaffold of Cur for the development of chemical tools or theranostics for metal−Aβ species.
INTRODUCTION
Alzheimer's disease (AD) is the most common, incurable neurodegenerative disease and is currently projected to affect 13.8 million Americans by 2050 [1] . Several pathological features are thought to be related to AD development, including accumulation of amyloid-β (Aβ) peptide aggregates, metal ion dyshomeostasis, and increased oxidative stress [2] [3] [4] [5] [6] [7] [8] [9] . An inter-relationship between these factors has been implied (e.g., metal binding to Aβ has been shown to facilitate peptide aggregation and to generate reactive oxygen species (ROS) in vitro), making the etiology of the disease elusive and complex [2] [3] [4] [5] [7] [8] [9] . These multiple pathological components have been investigated for gaining a fundamental understanding of the disease onset and progression and have been targeted for AD theranostic (diagnostic and therapeutic) purposes.
*Address correspondence to these authors at the Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 689-798, Korea; Tel: +82-52-217-5422; Fax: +82-52-217-5409; E-mail: mhlim@unist.ac.kr and Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI, 48202, USA; Tel: +1-313-577-2070; Fax: +1-313-577-8822; E-mail: mallen@chem.wayne.edu To modulate the reactivity (i.e., peptide aggregation and ROS scavenging) of the potential factors [specifically, Aβ and metal-associated Aβ (metal−Aβ)] that lead to AD pathogenesis, small molecules screened from natural products such as curcumin (Cur; Fig. 1 ) have been explored [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Cur is a naturally occuring phenol in turmeric, a popular Indian spice [20, 21] . Cur has been observed to inhibit the formation of Aβ oligomers and fibrils [11, 22] , aid in the prevention of neuronal damage [23] , and diminish oxidative stress [24] [25] [26] and amyloid accumulation [11] in an AD transgenic mouse model. Although Cur displays beneficial effects towards AD pathogenic factors (vide supra), its application as a chemical tool or theranostic agent has been limited due to its low solubility and stability in physiological environments [27] [28] [29] . Therefore, water-soluble Cur derivatives would be valuable to be investigated for inhibitory reactivity towards metal-free and metal-induced Aβ aggregation. One of the articles in this thematic issue by Huang and co-worker also reported one kind of Cur derivatives as effective inhibitors of Aβ aggregation [30] . Besides, a number of different types of Aβ aggregation inhibitors have been explored up to now [31] , including organic small molecules [32] , short peptides, nanoparticles, and metal complexes [33, 34] . (Fig. 1) , prepared by linkage of Gd(III)(DTPA) (Gd; Fig. 1 ; DTPA = diethylenetriamine pentaacetate; a clinically approved contrast agent) with Cur, was reported asa potential multimodal contrast agent to detect Aβ plaques in vitro, applicable to both magnetic resonance imaging (MRI) and fluorescence microscopy [35] . The ability of Gd-Cur to control metal-free and metal-induced Aβ aggregation pathways has not been reported, however. From our results and observations presented herein, together with the previous work [35] , Gd-Cur, in comparison to Cur-S, is demonstrated to be a viable molecular scaffold that could be a foundation for the development of a theranostic agent, capable of indicating Aβ plaques and redirecting metal-triggered Aβ aggregation.
Gd-Cur

MATERIAL AND METHODS
All reagents were purchased from commercial suppliers and used as received unless otherwise stated. The compounds Gd(III)(diethylenetriaminepentaacetate)-linked-2-(4-((1E,4Z,6E)-5-hydroxy-7-(4-hydroxy-3-methoxy-phenyl)-3-oxohepta-1,4,6-trien-1-yl)-2-methoxy-phenoxy)-N-(2-(3-(ptolyl)thioureido)ethyl)acetamide (Gd-Cur) [35] and 2,2'-((((1E,3Z,6E)-3-hydroxy-5-oxohepta-1,3,6-triene-1,7-diyl) bis(2-methoxy-4,1-phenylene))bis(oxy))diacetate (Cur-S) [36] were prepared following previously reported methods. Aβ 40 (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAI-IGLMVGGVV) and Aβ 42 (DAEFRHDSGYEVHHQKLVFF AEDVGSNKGAIIGLMVGGVVIA) were purchased from AnaSpec (Fremont, CA, USA). All ddH 2 O used during experiments was obtained from a Milli-Q Direct 16 system (Merck KGaA, Darmstadt, Germany). Optical spectra were recorded on an Agilent 8453 UV-visible (UV-vis) spectrophotometer. Transmission electron microscopy (TEM) images were recorded with a Philips CM-100 transmission electron microscope (Microscopy and Image Analysis Laboratory, University of Michigan, Ann Arbor, MI, USA) and a JEOL JEM-2100 Transmission Electron Microscope (UNIST Central Research Facilities, UNIST, Ulsan, Korea). A SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale, CA, USA) was employed for measurements of absorbance for the Trolox equivalent antioxidant capacity (TEAC), the MTT (MTT = 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide), and the Parallel Artificial Membrane Permeability Assay adapated for bloodbrain barrier (PAMPA-BBB) assays. 
Amyloid-β (Aβ) Peptide Experiments
Aβ experiments were performed according to previously published procedures [15, [37] [38] [39] [40] [41] . Aβ 40 
Gel Electrophoresis with Western Blotting
The resulting Aβ 40 /Aβ 42 species from both inhibition and disaggregation experiments were analyzed using gel electrophoresis followed by Western blotting with an anti-Aβ antibody (6E10, Covance, Princeton, NJ, USA) [15, [37] [38] [39] [40] [41] . Each sample (10 µL) was separated using a 10-20% tris-tricine gel (Invitrogen, Grand Island, NY, USA). The proteins were transferred onto a nitrocellulose membrane and blocked with bovine serum albumin (BSA, 3% w/v, SigmaAldrich, St. Louis, MO, USA) in tris-buffered saline (TBS) containing 0.1% Tween-20 (TBS-T) for 2 or 3 h at ambient temperature. The membranes were treated with an anti-Aβ antibody (6E10; 1:2,000) in 2% BSA (w/v in TBS-T) overnight at 4 °C. After washing, the membranes were probed with the horseradish peroxidase-conjugated goat anti-mouse antibody (1:5,000) in 2% BSA for 1 h at ambient temperature. Thermo Scientific Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA) was used to visualize protein bands.
Transmission Electron Microscopy (TEM)
TEM samples were prepared following a previously reported method [15, [37] [38] [39] [40] [41] . Glow-discharged grids (Formar/Carbon 300-mesh, Electron Microscopy Sciences, Hatfield, PA, USA) were treated with the samples (5 µL) from either the inhibition or disaggregation experiment for 2 min at ambient temperature. Excess sample was removed with filter paper. The grids were washed three times with ddH 2 O, stained with uranyl acetate (1% w/v, ddH 2 O, 5 µL) for 1 min, and dried for 15 min at ambient temperature.
Metal Binding Studies
The interactions of Cur, Cur-L, Gd-Cur, and Cur-S with Cu(II) and Zn(II) were investigated by UV-vis according to previously reported procedures [15, [37] [38] [39] [40] [41] . Solutions of Cur, Cur-L, Cur-S (10 µM for Cu(II) binding studies; 20 µM for Zn(II) binding studies), and Gd-Cur (10 µM for either Cu(II) or Zn(II) binding studies) in EtOH were treated with 1 to 2 equiv of CuCl 2 or ZnCl 2 followed by incubation for 5 min at ambient temperature prior to acquiring spectra.
Trolox Equivalent Antioxidant Capacity (TEAC) Assay
The antioxidant activity of compounds was determined by the TEAC assay employing cell lysates following the protocol of the antioxidant assay kit purchased from Cayman Chemical Company (Ann Arbor, MI, USA) with modifications [39] . Murine Neuro-2a (N2a) cells were used for this assay. This cell line purchased from ATCC (Manassas, VA, USA) was maintained in media containing 50% Dulbecco's modified Eagle's medium (DMEM) and 50% OPTI-MEM (GIBCO, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS, Sigma), 1% non-essential amino acids (NEAA, GIBCO), 2 mM glutamine, 100 units/mL penicillin, and 100 mg/mL streptomycin (GIBCO). Cells were grown and maintained at 37 °C in a humidified atmosphere with 5% CO 2 . For the antioxidant assay using cell lysates, cells were seeded in a 6 well plate and grown to approximately 80-90% confluence. Cell lysates were prepared according to the previously reported method with modifications [42] . N2a cells were washed once with cold (4 °C) phosphate buffered saline (PBS, pH 7.4, GIBCO) and harvested by gently pipetting off adherent cells with cold PBS. The resulting PBS solution was collected and the cell pellet was generated by centrifugation (2,000 × g for 10 min at 4 °C). Cell pellets were sonicated on ice (5 sec pulses, 5× with 20 sec intervals between each pulse) in 2 mL of cold (4 °C) assay buffer (5 mM potassium phosphate, pH 7.4, 0.9% NaCl, and 0.1% glucose). Cell lysates were centrifuged at 5,000 × g for 10 min at 4 °C. The supernatant was removed and stored on ice until use. To standard and sample in a 96 well plate was added 10 µL of the supernatant of cell lysates followed by compound, metmyoglobin, ABTS (2'2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)), and H 2 O 2 in sequential order. After 5 min incubation at ambient temperature on a shaker, the values of absorbance at 750 nm were recorded. Six concentrations (0.045, 0.090, 0.135, 0.180, 0.225, and 0.330 mM) of compounds and Trolox (Sigma-Aldrich; Trolox = 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid; dissolved in DMSO) were used. The percent inhibition was calculated according to the measured absorbance (% inhibition = (A 0 − A)/A 0 , where A 0 is the absorbance of the supernatant of cell lysates) and was plotted as a function of compound concentration. The TEAC value of ligands was calculated as a ratio of the slope of the standard curve of the compound to that of Trolox. The measurements were conducted in triplicate.
Cell Viability (MTT Assay)
The N2a cell line was maintained in media containing 50% DMEM and 50% OPTI-MEM (GIBCO) supplemented with 10% FBS (Sigma), 1% NEAA (GIBCO), 2 mM glutamine, 100 units/mL penicillin, and 100 mg/mL streptomycin (GIBCO). The cells were grown and maintained at 37 °C in a humidified atmosphere with 5% CO 2 . Cell viability upon treatment with compounds was determined using the MTT assay. N2a cells were seeded in a 96 well plate (15, Previously reported protocols with modification using the PAMPA Explorer kit (Pion, Inc. Billerica, MA, USA) were applied to our PAMPA-BBB experiment [38] [39] [40] [41] [43] [44] [45] . Each stock solution of compounds was diluted to a final concentration of 10 µM (1% v/v final DMSO concentration) with pH 7.4 Prisma HT buffer (Pion). The resulting solution (200 µL) was added to each of the wells of the donor plate (number of replicates per sample = 12). The BBB-1 lipid (Pion formulation, 5 µL) was used to coat the polyvinylidene fluoride (PVDF, 0.45 µM) filter membrane on the acceptor plate. The acceptor plate was placed on the top of the donor plate generating a "sandwich" and each well of the acceptor plate was filled with brain sink buffer (200 µL, Pion). Sandwiches were incubated at ambient temperature for 4 h without stirring. A microplate reader was used to obtain the optical spectra (250-500 nm) of the solutions in the reference, acceptor, and donor plates. The -logP e for each compound was calculated using the PAMPA Explorer software c. 3.5 (Pion). CNS+/-assignment was determined in comparison to compounds identified previously [43] [44] [45] . Compounds categorized as CNS+ likely have the ability to permeate through the BBB and be available in the CNS. Compounds assigned as CNS-likely have poor permeability through the BBB and, therefore, their bioavailability into the CNS is considered to be minimal.
RESULTS
Design Rationale
As shown in (Fig. 1) , the conjugate Gd-Cur was developed based on a rational structure-based approach, where a clinically approved MRI contrast agent (Gd) was appended onto Cur [35] , a nontoxic natural product that has been shown to have anti-amyloidogenic activity [11, 22] . Although Cur has multiple advantageous aspects, including anti-inflammatory effects and mediation of AD neuropathogenic factors, its biological applications are hindered due to its low water solubility and stability [27] [28] [29] . Thus, to overcome these limitations, water soluble Cur derivatives, GdCur and Cur-S, were investigated to determine whether the beneficial characteristics (i.e., nontoxicity, antioxidant activity, and control of Aβ aggregation) of Cur are retained after structural modification to enhance biological use through increased solubility. Either linkage of Gd to Cur (Gd-Cur; Fig. 1) or substitution of the phenolic hydroxyls to sodium acetate (Cur-S; Fig. 1 ) vastly improved the solubility in buffered solution (ca. mM-M in aqueous media).
Influence on Metal-Free and Metal-Triggered Aβ Aggregation In Vitro
The control of Gd, Cur, Cur-L, Gd-Cur, and Cur-S towards metal-free and metal-induced Aβ aggregation in vitro was examined through two experiments: inhibition (modulation of Aβ aggregate formation) and disaggregation (transformation of preformed Aβ aggregates) (Figs. 2 and 3 ) [15, [37] [38] [39] [40] [41] . The Aβ species generated from both experiments were monitored via gel electrophoresis followed by Western blot (gel/Western blot) with an anti-Aβ antibody (6E10) for analyzing the distribution of molecular weight (MW), as well as transmission electron microscopy (TEM) for visualizing morphological changes [15, [37] [38] [39] [40] [41] .
The inhibition studies, as depicted in (Fig. 2) , demonstrated different reactivity of Gd, Cur, Cur-L, Gd-Cur, and Cur-S towards the formation of metal-free and metalinduced Aβ aggregates composed of either Aβ 40 or Aβ 42 . Through the studies by gel/Western blot, in the case of samples containing Cu(II) and Aβ 40 , noticeable reactivity was only observed upon treatment of peptide with Cur-L ( Fig.  2A, lane 3 , left) and some reactivity with Cur and Gd-Cur ( Fig. 2A, lanes 2 and 4, left) . Gd or Cur-S was not able to modulate both metal-free and metal-triggered Aβ 40 aggregation ( Fig. 2A, lanes 1 and 5, left) . Any significant difference between compound-free and compound-treated samples was not indicated from metal-free Aβ 40 and Zn(II)−Aβ 40 samples. Upon incubation of Cu(II)-treated Aβ 40 with Cur, Cur-L, or Gd-Cur, smaller amorphous Aβ 40 aggregates were observed by TEM; however, Gd and Cur-S presented similar size and morphology of Aβ 40 species compared to compound-free conditions (Fig. 2B) . In the absence and presence of metal ions, the addition of small molecules to Aβ 42 showed overall similar reactivity patterns relative to Aβ 40 samples. The distinct distribution of MW, in reference to compound-free Aβ 42 , was observed only in Cu(II)-added samples incubated with Cur, Cur-L, or Gd-Cur ( Fig. 2A, lanes 2-4, right) . From these samples, TEM images revealed shorter, thinner, and less dense fibrils upon Cur, Cur-L, or Gd-Cur treatment (Fig. 2B) . Compound-untreated and Gd-/Cur-Sincubated Cu(II)−Aβ 42 species were indistinguishable from one another, displaying thicker, dense fibrils (Fig. 2B) .
Furthermore, the disaggregation studies indicated comparable reactivity of compounds with Aβ 40 to that in the inhibition experiment (vide supra) (Fig. 3A) . Reactivity of Gd, Cur, Cur-L, Gd-Cur, or Cur-S towards metal-free Aβ 40 aggregates was not significantly visualized even after 24 h incubation (Fig. 3A, lanes C-5, left) . In addition, slight reactivity of Cur, Cur-L, and Gd-Cur towards Zn(II)-triggered Aβ 40 aggregates was shown (Fig. 3A, lanes 2-4, left) . On the other hand, when Cu(II)-induced Aβ 40 aggregates were incubated with Cur, Cur-L, or Gd-Cur for 24 h, Aβ 40 species showing a wide range of MW were observed (Fig. 3A, lanes  2-4, left) . Morphological changes of preformed Cu(II)−Aβ 40 aggregates upon compound incubation were distinguished by TEM. Unstructured Aβ 40 aggregates were detected for Cu(II)−Aβ 40 aggregates treated with Cur, Cur-L, or Gd-Cur (Fig. 3B, left) . In the case of Aβ 42 , the samples with Zn(II)−Aβ 42 and Cur or Gd-Cur (Fig. 3A, lanes 2 and 4,  right) exhibited a different MW distribution from compoundfree Aβ 42 analogues. Similar to Aβ 40 , Cur, Cur-L, or Gd-Cur was able to redirect preformed Cu(II)-Aβ 42 aggregates indicating various-sized peptide species (Fig. 3A, lanes 2-4) . Reactivity was also shown upon the addition of Gd with Cu(II)− Aβ 42 aggregates (Fig. 3A, lane 1) . TEM studies demonstrated that thinner or shorter fibrils, amorphous aggregates, or a mixture of the two Aβ conformations were resulted from preformed Cu(II)−Aβ 42 aggregates added with Gd, Cur, Cur-L, or Gd-Cur (Fig. 3B, right) .
Metal Binding Properties
Cu(II) or Zn(II) binding of Cur, Cur-L, Gd-Cur, and Cur-S was confirmed by UV-vis (Fig. 4) . Variation in the UV-vis spectra, either as new optical bands or changes in absorbance intensity, was observed upon addition of CuCl 2 or ZnCl 2 (1 to 2 equiv) to EtOH solutions of Cur, Cur-L, Gd-Cur, or Cur-S. New optical bands after CuCl 2 treatment were detected at ca. 430 and 455 nm (for Cur); 427 and 450 nm (for Cur-L); 424 and 459 nm (for Gd-Cur); and 353, 430, and 448 nm (for Cur-S) (Fig. 4A) . In the presence of ZnCl 2 , optical shifts were observed from 417 to 439 nm (for Cur); 415 to 441 nm (for Cur-L); 318 to 504 nm (for GdCur); and 342 to 503 nm (for Cur-S) (Fig. 4B) . It should be noted that minimal optical change was indicated for Cur and Cur-L when ZnCl 2 was introduced (Fig. 4B) .
Radical Scavenging Capability, Cytotoxicity, and BloodBrain Barrier (BBB) Permeability
The ability of Gd, Cur, Cur-L, Gd-Cur, and Cur-S to scavenge free radicals was first evaluated by the cell lysatebased Trolox equivalent antioxidant capacity (TEAC) assay [39] that measures the capability of compounds to inhibit the oxidation of ABTS to ABTS cation radicals (ABTS • + ; ABTS = 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) in the presence of metmyoglobin and H 2 O 2 in a complex biological environment. Gd and Gd-Cur had similar radical scavenging capacity as Trolox (vitamin E analogue) (1.2 ± 0.27 for Gd; 0.99 ± 0.12 for Gd-Cur) and a slightly lower radical quenching ability was observed with Cur-S (0.67 ± 0.06). Cur and Cur-L showed distinct differences in radical scavenging activity to Trolox (TEAC values = 0.27 ± 0.15 and 3.72 ± 1.69, respectively); however, precipitation was noted with Cur and Cur-L under the conditions using cell lysates, owing to their poor solubility in aqueous media.
The cytotoxicity of Gd-Cur and Cur-S, in the absence and presence of Aβ 40 /Aβ 42 with and without metal chloride salts (CuCl 2 or ZnCl 2 ), was determined using the MTT assay (Fig.  5) [15, [37] [38] [39] [40] [41] . Due to the insolubility of Cur and Cur-L in an aqueous environment, the cytotoxicity of the two compounds was not assessed. Murine Neuro-2a (N2a) neuroblastoma cells were incubated with various concentrations of compounds (2.5-50 µM). No toxicity was observed for both compounds up to 50 µM (Fig. 5A) . Upon the treatment of CuCl 2 (2.5-50 µM) with a compound ([M(II)]:[compound] = 1:1), Gd-Cur and Cur-S presented relatively low cytotoxicity (ca. ≥ 80% cell viability; Fig. 5B ) and slightly higher cell viability in comparison to cells were treated only with Cu(II). In the case of Zn(II), relatively high cell viability (ca. ≥ 90%) was observed for Zn(II) only or Zn(II) with Gd-Cur or Cur-S even at higher concentrations of Zn(II) and compounds (Fig. 5B) . We further examined the effect of Gd-Cur or Cur-S upon mitigation of Aβ-/metal−Aβ-induced cytotoxicity. N2a cells were introduced with Aβ 40 (20 µM), CuCl 2 or ZnCl 2 (20 µM), and a compound (20 µM) followed by incubation for 24 h (Fig. 5C) . Toxicity was observed when cells were treated with Aβ in both the absence and presence of metal ions. Moreover, cell survival was slightly improved with Gd-Cur noticeably than that of Aβ 40 -/metal-Aβ 40 -added cells (Fig. 5C) . Lastly, the blood-brain barrier (BBB) permeability of Cur, Gd-Cur, and Cur-S, for potential brain applications, was predicted initially by Lipinski's rules and log BB calculations [43, 44, 46, 47] ; the theoretical values indicating drug-like characteristics and possible BBB permeability. Moreover, the theoretical values have been supported by an in vitro Parallel Artificial Membrane Permeability Assay adapted for the BBB (PAMPA-BBB) ( Table 1) [39-41, 43, 44] to determine permeability values (−logP e ). These theoretical and measured values, in comparison to known BBBpermeable molecules, suggest that Cur may potentially diffuse through the BBB, while Gd-Cur and Cur-S may or may not be BBB permeable.
DISCUSSION
Current limited knowledge of the pathological factors (e.g., Aβ, metal ions, and metal−Aβ) and their interrelationship towards AD onset and progression has hindered the development of theranostic agents for this neurological disorder. A hybrid (Gd-Cur; Fig. 1 ) of an MRI contrast agent (Gd) and Cur was previously synthesized as a diagnostic agent and has been determined to be a viable contrast agent with the ability to target Aβ fibrils [35] . Cur has been widely studied and has been found to exhibit antiamyloidogenic properties [11, 22] . Therefore, this potential diagnostic tool was investigated to ascertain whether GdCur could be used towards therapeutic ends. In addition, the use of Cur, which exhibits auspicious characteristics towards AD pathological factors, has been impeded due to its low solubility and stability under physiologically relevant conditions [27] [28] [29] ; thus, a water-soluble derivative, Cur-S, along with Gd-Cur, was investigated for modulating metalfree and metal-induced Aβ aggregation, scavenging radical species, as well as being nontoxic and BBB permeable.
Cur, Cur-L, and Gd-Cur were shown to redirect both Aβ 40 and Aβ 42 aggregation pathways more noticeably in the presence of Cu(II). Some reactivity of Cur and Gd-Cur towards preformed Zn(II)-mediated Aβ 40 /Aβ 42 aggregates was observed, while no apparent control of metal-free Aβ aggregation by any Cur derivatives and Gd was indicated. Cur-S showed no reactivity in either inhibition or disaggregation studies with both Aβ 40 and Aβ 42 , suggesting that slight structural modification of the phenol group (i.e., substitution of both phenolic hydroxyls) might influence interactions with Aβ. Overall, Cur, Cur-L, and Gd-Cur are preferentially reactive with metal−Aβ over metal-free Aβ, and Cu(II)/Zn(II) binding to Cur derivatives was confirmed by UV-vis. As another biological activity, Gd-Cur and Cur-S have similar and less radical scavenging capability compared to Trolox, respectively, which implies that the phenol functionality might be an important moiety of Cur for its biological activities [48, 49] . Both Gd-Cur and Cur-S display relatively low toxicity in living cells based on the MTT assay. The compounds, however, may be limited to applications in the brain due to their expected low ability for BBB penetration.
